Program
Sinovac PCV24 formulation 1
Also written as “Sinovac PCV24 formulation 2” and “Sinovac PCV24”.
Its studies are mostly in Pneumococcal Infections, led by Sinovac Biotech.
Furthest: phase 2, since Nov 24, 20254 company-led studies, 2 open or running
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Sinovac Biotech | 42 open or running | phase 2since Nov 24, 2025 | Jun 19, 2024 | none ahead |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jun 19, 2024First study: phase 1 study in Pneumococcal InfectionsFirst studyNCT06474377 · 170 enrolled · China
- Aug 8, 2024Phase 1 study in Pneumococcal InfectionsNCT06550830 · 119 enrolled · China
- Jan 23, 2025Phase 1 study in Pneumococcal InfectionsNCT06800261 · 180 planned · China
- Nov 24, 2025Phase 2 study in Pneumococcal InfectionsPhase 2 reachedNCT07300644 · 420 planned · China
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07300644Pneumococcal Infections · China | 2 | Recruiting | Sep 2026 | 420 |
| NCT06800261Pneumococcal Infections · China | 1 | Recruiting | Jun 2026 | 180 |
| NCT06550830Pneumococcal Infections · China | 1 | Completed | Jun 25, 2025 | 119 |
| NCT06474377Pneumococcal Infections · China | 1 | Completed | Aug 26, 2024 | 170 |
How it is read
Names in the registry
- “Sinovac PCV24 formulation 1”, 2 entries
- “Sinovac PCV24 formulation 2”, 2 entries
- “Sinovac PCV24”, 2 entries
Conditions, from the studies’ own filings
- Pneumococcal Infections, 4 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.